Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News ImmunoGen Inc. IMGN

Immunogen Inc is a clinical-stage biotechnology company from the United States. Its focus is antibody-drug conjugate, or ADC, technology, which uses an antibody that fixes on a target (its antigen) found on tumor cells to deliver a specific cancer-killing agent. The technology is used in Kadcyla (ado-trastuzumab emtansine)--a registered trademark of Genentech, a member of the Roche Group--to kill solid tumors. Companies such as Amgen, Genentech/Roche, Lilly, Novartis, Sanofi, and Takeda have...

The Power Play by The Market Herald
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Stock Price Chart (NDAQ:IMGN)

Fundamentals Snapshot (NDAQ:IMGN)

Bullboard Posts (NDAQ:IMGN)

IMGN - Wednesday Rundown, Thursday Expectations

<< View Post To Watch Video >>
HDavis - December 1, 2021

IMGN - Tuesday Rundown, Wednesday Expectations

<< View Post To Watch Video >>
HDavis - November 30, 2021

IMGN - Is Set Up For A Run

<< View Post To Watch Video >>
HDavis - November 30, 2021

this one is holding up well

considering the markets,so glta shareholders.
coolfooldumbguy - February 25, 2020

still holding this stock

my new target price for this year is over $10 plus per share and MORE,so glta shareholders.
coolfooldumbguy - February 14, 2020

past my target price

but won't sell it yet,my target was the $6 per share mark,but because this stock blew past it with all kinds of strength showing on...
coolfooldumbguy - February 14, 2020